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Proteins which bind with high affinity Ins 1,3,4,5-P4 or Ins 1,4,5-Ps were solubilized from porcine cerebellar membranes. Both binding activities 
were separated by heparin-agarose chromatography. T e Ins 1,3,4,5-P4 receptor was partially purified with an approximately IOOO-fold enrichment 
as compared to the membrane preparation. I  the receptor-enriched pr paration theIns 1,3,4,5-PJ3 binding protein had an afhnity (&) for Ins 
1,3,4,5-P,, of 4.6 nM. Ins 1,3,4,5,6-P> displaced [3H]Ins 1,3,4,5-P,binding with a comparable affinity. The Ins 1,3,4,5-qbinding protein displayed 
high selectivity for Ins 1,3,4,5-P, over other inositolphosphates (ICa for Ins 1,4,5,6-P, 150 nM, for Ins-P, 1 PM and for Ins 1,3,4-P3 5PM). Most 
Importantly, Ins 1,4,5-P3 did not displace [3H]Ins 1,3,4,5-P4binding at concentrations up to 10 PM. Binding of Ins 1,3,4&LP4 was maximal in the 
pH range between 4.5 and 6, was stable with Ca*+ concentration varied from 1 nM to 1 mM, and was suppressed by heparin (ICH, about 2 nM). 
The high affinity receptor for Ins 1,3,4,5-P, reported here, which is distinct from the Ins 1,4,5-PJ receptor might allow to evaluate the possible 
functional role of Ins I ,3,4,5-P, in the cellular signal transduction. 
Inositol 1,3,4,5-tetrakispbosphate; Inositol 1,4,5-t~sphosphate; Inositolphosphate receptor; Heparin 
1. INTRODUCTION 
Inositol 1,4,5_trisphosphate (Ins 1,4,5-P3; Ins-PJ) is 
generated in many different cell types as a second 
messenger after stimulation by hormones [ 11. The role 
of Ins-P3 has been clarified by physiological and 
biochemical experiments demonstrating that this reac- 
tion product of phospholipase C releases Ca” from in- 
tracellular stores [l]. Conclusive evidence for the func- 
tion of Ins-P3 was given recently by inserting the 
isolated protein (Ins 1,4,5-P3 receptor) into lipid vesic- 
les. Ferris et al. [2] demonstrated in this reconstituted 
preparation that Ins-P3 mediates Ca2+ flux. Ins-P3 is 
rapidly metabolized and thus inactivated by two routes 
(31. Ins-P3 is either dephosphorylated by Ins 1,4,5-P3 5- 
phosphatase to Ins 1 ,4-Pz, which has no effect on Ca2+ 
levels [3]. Alternatively, Ins 1,4,5-Ps 3-kinase yields the 
phosphorylation product inositol 1,3,4,5_tetrakisphos- 
phate (Ins 1,3,4,5-P4; Ins-P4) [4]. Ins-P4 has been sug- 
gested also to be involved in Ca2+ homeostasis. Several 
still controversial hypotheses have been put forward 
suggesting mechanisms of action of Ins-P4 such as CaZf 
sequestration into internal pools [5], or regulation of 
the accessibility of different types of Ca2+ pools [6]. 
Recently we have demonstrated the existence of high- 
affinity receptors for Ins-P4 in cerebellar membranes 
Abbreviations: Ins-P4 (Ins 1,3,4,5-P4), D-myo-inositol 1,3,4,5-Pa; 
Ins-Pa (Ins 1,4,5-Ps), D-myo-inositol 1,4,5-P? 
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[7]. The receptor showed a high selectivity for Ins 
1,3,4,5-P4 among several inositolphosphates tested. We 
have used the binding protein preparation from pig 
cerebellum to quantify cellular contents of Ins-P4 in a 
neuronal cell line stimulated with the peptides brady- 
kinin [7] or endothelin [8]. Our method greatly facili- 
tates measurements of Ins-P4 contents in tissues in- 
cubated with various hormones. Thus, evidence might 
be gathered for a possible role of Ins-P4 in cellular 
signal transduction involving inositolphosphates. 
However, a definitive proof for a function of Ins-P4 
can only be established by isolating the receptor for Ins- 
P4 and demonstrating the functional properties of the 
protein. Here we report solubilization of the Ins-P4 
receptor from pig cerebellum and its partial purifica- 
tion. Furthermore, some characteristics of the receptor 
were investigated such as the influence of pH, of Ca2’ 
concentration and of various polyglycanes on binding. 
2. MATERIALS AND METHODS 
2.1. Materials 
[‘H]Ins(l,3,4,5)P, (spec. act. 755-1330 GBq/mmol), [‘HI- 
Ins(l,4,5)Pj (spec. act. 1.2 TBq/mmol) were from Amersham, 
Braunschweig, FRG. Ins(1,3,4,5)P4, Ins(1,3,4)Ps, Ins(1,4,5)Ps, 
potassium salts, Ins(1,2,3,4,5,6)Pa, sodium salt, were from Calbio- 
them, Frankfurt, FRG. Ins(1,4,5)Ps, Ins(1,3,4,5)P4, Ins(1,4,5,6)Pd, 
Ins(1,3,4,5,6)Ps, ammonium salts were from Boehringer, Mannheim, 
FRG. Heparin (molecular weight 4000-6000), pentosan polysulfate, 
de-N-sulfated heparin, sodium salts, were from Sigma, Deisenhofen, 
FRC. Heparin-agarose, Amido Schwarz and Bio-Gel P-4 were from 
Biorad, Mu&hen, FRG. Brij 58 (polyoxyethylene monocetyt ether) 
~bt~shed by Eisevier Science Publishers B. V. (Eiom~~i~a~ Divi_qion) 
00145793/9O/S3.50 0 1990 Federation of European Biochemical Societies 194 
Volume 268, number 1 FEBS LETTERS July 1990 
was from Serva, Heidelberg, FRG. All other chemicals were of 
analytical grade obtained from Merck, Darmstadt, FRG. 
2.2. Methods 
Membranes from pig cerebellum were prepared as described [7]. 
Briefly, the tissue was homogenized in buffer containing (mM) Tris- 
HCl50, EDTA 1, mercaptoethanol 1, pH 7.7, at 4”C, using a Waring 
Blendor and centrifuged (30 min, 35 000 g). Subsequently the pellet 
was twice resuspended, homogenized and centrifuged. The final 
pellet, resuspended in buffer at a concentration of 20 to 30 mg/ml, 
was homogenized using a Potter-Elvejhem homogenizer and kept at 
- 20°C. 
For solubilization the membrane suspension was centrifuged (10 
min, 27 000 g). The resulting membrane pellet was supplemented with 
solubilization buffer at a volume ratio of buffer to membranes of 5: 1. 
The solubilization buffer contained (mM) Tris-HC150, EDTA 1, mer- 
captoethanol 5, pH 7.5, and 1.5 070 (w/v) Brij 58. The mixture was 
gently stirred at 4°C for 1 h and centrifuged in a ultracentrifuge (1 h, 
140 000 g). After centrifugation the supernatant without the vesicular 
layer was applied at a flow rate of 100 ml/h to a heparin-agarose col- 
umn (35 ml, 4 cm diameter) equilibrated with buffer A (mM): Tris- 
HCl 50, EDTA 1, mercaptoethanol 1, pH 7.5, and 0.1 % (w/v) Brij 
58. After washing the column with buffer A, proteins were eluted by 
stepwise increasing the NaCl concentration to 0.25, 0.4, 0.5 and 0.8 
M. The peak of Ins-P4 binding activity detected in the fractions of the 
0.8 M NaCl eluate was pooled and used either for analysis or for re- 
chromatography on a second, smaller heparin-agarose column (1.5 
ml, 1 cm diameter) which was eluted with buffer A containing NaCl 
at concentrations of 0.4 or 0.8 M. 
Ins-P4 binding activity was assayed in solubilized and purified 
preparations by spun-column chromatography. Samples were in- 
cubated for 20 min at 4°C with [3H]Ins 1,3,4,5-P4 (concentration 
0.1 l-0.20 nM) in a total volume of 280 pl incubation buffer (in mM: 
EDTA 1, sodium acetate 25, pH 5.0, potassium phosphate 25, pH 
5.0, mercaptoethanol 1, and 0.1% (w/v) Brij 58). An aliquot of the 
incubation mixture was applied to columns containing Biogel P-4 (1 
ml packed resin) and centrifuged (2 min, 3500 g) to separate bound 
from unbound ligand. The void volume of the columns was sup- 
plemented with 3.5 ml scintillation liquid (Aqualuma plus, Baker). 
Also Ins-Pa binding activity was determined by spun-column 
chromatography using the incubation buffer described previously [7]. 
Radioactivity was determined taking quenching into account by 
automatic correction with a quench standard curve (LKB, 1214 Rack- 
beta). Radioligand binding to membranes was measured as in [7]. 
Protein contents of samples of detergent-solubilized membranes or 
of detergent containing eluates from column chromatography were 
measured by the Amido Schwarz method described by Schaffner and 
Weissman [9] modified for Brij 58 containing samples. 
3. RESULTS 
Membranes from pig cerebellum were treated with 
detergent solutions for 1 h at 4°C. With 1.5% of the 
detergent Brij 58, a large part of Ins-P4 binding activity 
could be recovered in the supernatant obtained after 
centrifugation at 140 000 g. Binding activity was 
measured using the incubation conditions, which had 
been found to be favourable for Ins-P4 binding in mem- 
branes. However, at the concentration of 1.5 % Brij 58 
used for solubilization the detergent reduced Ins-P4 bin- 
ding (data not shown). Treatment of solubilized mem- 
branes with trypsin abolished specific Ins-P4 binding 
consistent with the notion that a protein represents the 
binding site. 
Ins-P4 binding to the high affinity receptor in 
cerebellar membranes is inhibited by heparin [7]. Thus, 
we tried to purify the receptor by affinity 
chromatography on heparin-agarose. The solubilized 
preparation was applied to heparin-agarose and eluted 
by stepwise increasing the NaCl concentration in the 
elution buffer. The data from a typical column run are 
shown in Table I. With NaCl concentrations of 0.25 M, 
0.4 M, 0.5 M and 0.8 M, the lowest total Ins-P4 binding 
activity (0.4 pmol) was detected in the 0.5 M fraction 
and the highest otal binding activity of 6.7 pmol in the 
0.8 M fraction (Table I). 
Since also the Ins 1,4,5-P3 receptor adheres to 
heparin-agarose [ 101 we measured Ins-P3binding activi- 
ty, in parallel, in the same fractions. Most of the Ins-P3 
binding was found in the fraction obtained with 0.4 M 
NaCl (total 7.8 pmol), whereas very little binding could 
be detected in the 0.8 M fraction (0.15 pmol). Binding 
activities were determined in samples dialyzed with buf- 
fer A containing no Brij 58. This desalting procedure 
avoided a possible interference of varying salt concen- 
trations with inositolphosphate binding. The solubiliz- 
ed membranes displayed significantly more binding ac- 
tivity for Ins-P3 than for Ins-P4. In the fraction eluted 
Table I 
Elution profile of Ins 1,3,4,5-P4 and Ins 1,4,5-P3 binding activities from heparin-agarose chromatography. Membranes from 
pig cerebellum prepared as described [7] were suspended at 200 mg wet weight per ml buffer containing Brij 58 (1.5%). After 
solubilization and centrufigation, as described in Methods, the 140 000 x g supernatant was applied to a heparin-agarose 
column. Fractions of the eluates with increased absorbance at 280 nm and with inositolphosphate binding activity were pool- 
ed and dialyzed in buffer A devoid of Brij 58. Inositolphosphate binding activities shown here were determined with 0.19 
nM [3H]Ins 1,3,4,5-P4 or [“HIIns 1,4,5-Ps in the incubation mixture and analyzed by spun-column chromatography, as 
described in Methods. For measuring unspecific binding, 0.5 PM Ins 1,3,4,5-P4 or CM Ins 1,4,5,-Ps were added. Specific 
binding activities (= total binding - unspecific binding) of the dialyzed samples assayed in duplicate are given. Results are 
representative for 4 experiments. 
Fraction 
Total protein (mg) 
Specific Ins-P4 binding 
(fmol/mg protein) 
Specific Ins-PI binding 
(fmol/mg protein) 
Solubilized 
membranes 
414 
19.6 
57.7 
0.25 M NaCl 
eluate 
90.8 
32.6 
35.8 
0.4 M NaCl 
eluate 
36.3 
80.4 
217 
0.5 M NaCl 
eluate 
0.55 
741 
327 
0.8 M NaCl 
eluate 
0.68 
9818 
602 
195 
Volume 268, number 1 FEBS LETTERS July 1990 
with 0.8 M NaCI, specific Ins-Pdbinding was 9.8 
pmol/mg protein, whereas Ins-P3 binding of only 0.22 
pmol/mg protein could be detected. Thus binding ac- 
tivities for Ins-Pdand for Ins-P3 were efficiently 
separated by heparin-agarose chromatography. 
Using the fractions of the 0.8 M NaCl eluate with 
high binding activity, some of the properties of the Ins- 
P4 receptor were determined. The dependence of Ins-P4 
binding on pH is demonstrated in Fig. 1. Specific bin- 
ding is characterized by a bell-shaped curve with 
minimal binding below pH 4.25 and above pH 6.5. The 
maximum was reached between pH 4.5 and 6. 
Unspecific binding remained almost constant over the 
whole pH range tested. 
In some experiments the Ins-P4 binding activity 
recovered in the 0.8 M NaCl eluate from heparin- 
agarose chromatography was dialyzed and re-applied to 
heparin-agarose. The eluate obtained with 0.4 M NaCl 
was discarded since it contained very little Ins-P4 
binding activity. In the subsequent 0.8 M NaCl eluate, 
however, in a typical experiment binding activity for 
Ins-P4, determined as described in Table I, was 12.5 
pmol/mg protein. Whereas in the 0.8 M NaCl eluate 
from the first heparin-agarose column Ins-P3 binding 
activity was still 10% of Ins-P4 binding activity, the cor- 
responding value after the second heparin-agarose col- 
umn was only 4%. The ability of heparin to displace 
Ins-P4 binding was tested in the receptor-enriched frac- 
tion obtained from the second affinity column (Fig. 
2A). Binding was half-maximally inhibited by 15 pg/l 
heparin, a concentration of about 2.5 nM. De-N- 
sulfated heparin was about one order of magnitude less 
potent, whereas pentosan polysulfate displayed an in- 
termediate affinity. 
Fig. 2B shows binding characteristics of the Ins-P4 
receptor which has been partially purified by two 
heparin-agarose columns. [3H]Ins-P4 binding was 
displaced by unlabelled Ins-P4 with half-maximal in- 
hibition at 6 nM (Fig. 2B). Even after storage for 10 
days at 4”C, the protein still showed the same binding 
characteristics. Scatchard analysis (Fig. 2B, inset) gives 
an affinity constant & of 3.3 nM and a binding capaci- 
ty of 1.6 nM, which corresponds to 300 pmol/mg pro- 
tein. The mean value for Kd was 4.6 + 1.8 nM (n = 6). 
The specificity of the Ins 1,3,4,5-P4 binding site was 
characterized by adding several inositololigophos- 
phates. Ins 1,3,4,5,6_pentakisphospate displaced 
[3H]Ins 1,3,4,5-P4 binding nearly as potently as Ins 
1,3,4,5-PA. Ins 1,4,5,6-P4 suppressed Ins 1,3,4,5-P4 
binding half-maximally at 150 nM. The other inositol- 
phosphates tested displayed much lower affinity. Inosi- 
tolhexakisphosphate and Ins 1,3,4-P3 inhibited binding 
of Ins 1,3,4,5-P4 half-maximally at about 1 and 5 PM, 
respectively. Ins 1,4,5-P3, however, had no influence at 
concentrations up to 10 PM (data not shown). Also the 
influence of Ca2+ on Ins 1,3,4,5-P4 binding was tested 
by adjusting the Ca2+ concentration with EGTA. Ca2+ 
196 
p‘ 60 
F 1 /"\ 
PH 
Fig. 1. Influence of pH on Ins 1 ,3,4,5-P4 binding. Membrane proteins 
were solubilized, as described in Methods and separated by heparin- 
agarose chromatography. From the eluate with buffer A containing 
0.8 M NaCl the fractions containing Ins-P4 binding activity were com- 
bined and used for the experiment. For determining binding, the pH 
was adjusted to the various values indicated in the two buffering com- 
ponents (acetate and phosphate) of the incubation buffer separately. 
Specific binding (A) is obtained by subtracting unspecific binding (m) 
from total binding (0). Unspecific binding represents the amount of 
binding not displacable by 0.4 PM unlabelled Ins 1,3,4,5-Pd. [‘HIIns- 
P4 binding was measured by spun-column chromatography. Here and 
in Fig. 2 data representative for at least 2 further experiments with 
comparable results are shown. 
Fig. 2. Characteristics of the partially purified Ins 1,3,4,5-P4 receptor. 
(A) Inhibition of Ins 1,3,4,5-P4 binding by heparin and related 
analogues. (B) Affinity of the partially purified protein for Ins 
1,3,4,5-P+ In A varying amounts of heparin (o), de-~-sulfated 
heparin (A) or pentosan polysulfate (m) were present during the in- 
cubation. In (B) 0.14 nM [3H]Ins 1,3,4,5-P4 and varying concentra- 
tions of unlabelled Ins 1,3,4,5-P., were present. (Inset) Scatchard 
analysis of Ins 1,3,4,5-P4 binding from the data shown in (B). For 
both experiments (A and B) fractions eluted from the second heparin- 
agarose column with buffer A containing 0.8 M NaCl were used. 
Values represent means obtained from duplicate incubations and er- 
ror bars give the deviations. Protein concentration in the assay mix- 
tures for determining binding activity was 5 ag/ml in A and in B. 
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did not affect binding of Ins 1,3,4,5-P4 at a range of 
concentrations from about 1 nM to 1 mM (not il- 
lustrated). 
4. DISCUSSION 
We have identified binding sites for Ins 1,3,4,5-P4 
with an affinity of approximately 1 nM and a concen- 
tration of 0.22 pmol/ mg protein in membranes 
prepared from porcine cerebellum [7]. The density of 
Ins 1,4,5-P3 binding activity with high affinity (Kn14 
nM) was 7.3 pmoll mg protein in these membranes 
from pig cerebellum, thus exceeding the Ins 1,3,4,5-P4 
receptor concentration by a factor of 30 to 40. 
Both binding activities, for Ins-P3 and for Ins-P4, 
were solubilized with high efficiency by using the no- 
nionic detergent Brij 58. The solubilized Ins-P4 receptor 
displayed an affinity comparable to that of the receptor 
embedded in the membrane. The Ins-P, receptor has 
already been purified to homogeneity from rat 
cerebellum [lo] and the primary structure of the Ins-P3 
receptor has been deduced recently from cDNA cloning 
analysis [ll]. Like Ins-P3 binding [12], also Ins-P4 bind- 
ing is suppressed by heparin 171. Therefore the solubiliz- 
ed preparation was subjected to hep~in-affinity 
chromatography. Both binding activities adhered to 
heparin-agarose and were eluted with a series of buffers 
with increasing ionic strength. The maximal Ins-P3 bin- 
ding activity was eluted at 0.4 M NaCl. This pattern is 
similar to the results obtained by Maeda et al. [13] and 
by Supattapone t al. [lo] reporting that the high affini- 
ty Ins 1,4,5-P3 receptor can be eluted from heparin- 
agarose by a buffer containing 0.5 M NaCl. Maximal 
Ins 1,3,4,5-P4 binding, however, was found in the frac- 
tion eluted with 0.8 M NaCl. 
Thus, Ins-P3 and Ins-P4 binding activities can be 
largely separated by heparin-agarose chromatography. 
After a second heparin-agarose column we obtained a 
fraction with a substantial concentration of the high af- 
finity Ins-P4 receptor (300 pmol/mg protein). This gives 
an approximately lOOO-fold purification of Ins-P4 bin- 
ding activity in comparison with the membr~e 
preparation (0.2 pmollmg protein). In the final fraction 
obtained after the second heparin-agarose column, 
specific Ins-P3 binding was very low amounting to 
about 4% of Ins-P4 binding activity. During prepara- 
tion of the present manuscript Theibert et al. 1141 
reported the solubilization of an Ins-P4 binding protein 
from rat cerebellum. However, Ins-P4 and Ins-P3 bin- 
ding proteins could not be separated by heparin 
chromatography. 
The characteristics of Ins-P4 binding activity which 
we found after purification resemble those detected in 
the membrane prep~ation. The selectivity for the 
various inositolphosphates was similar apart from the 
fact that Ins 1,3,4,5,6-P5 inhibited [3H]Ins 1,3,4,5-P4 
binding with an ICSO close to that for non-radioactive 
Ins 1,3,4,5-P4. The I& value for Ins 1,4,5,6-P4 was 
150 nM, for Ins 1,3,4-P3 5 PM and for Ins-P6 1 FM. The 
fact that Ins I ,4,5-P3 showed no inhibition up to 10 PM 
reveals most clearly that the protein isolated is distinct 
from the Ins 1,4,5-P3 receptor. 
Some of the properties of the Ins-P4 binding activity 
were determined: variation of pH showed that Ins-P4 
binding was maximal in the range between 4.5 and 6. 
Ins-P3 binding to its high affinity receptor, however, 
showed a different pH dependency. Ins-P3 binding in- 
creased with raising the pH above 5 and reached a max- 
imal value at a pH of about 8.5 1121. Ca*+ did not in- 
fluence Ins-P4 binding at a range of concentrations 
from nano- to millimolar, similarly to the lack of an ef- 
fect of Ca*+ on binding of Ins-P3 to the purified Ins-P3 
receptor [lo]. 
A remarkable property of Ins-P4 binding activity is 
the inhibition by heparin and related polyglycans. 
Heparin suppresses high-af~~ty Ins-P3 binding [ 12,151 
and blocks Ins-P3-induced Ca2+ release [ 16,171. These 
results have been exploited frequently for using heparin 
as an experimental tool in the following context: disap- 
pearance of a cellular effect after injection of heparin 
was taken as evidence that Ins 1,4,5-P3 was involved in 
the activation process [IS]. The similarly high affinity 
of heparin for the Ins 1,3,4,5-P4 receptor shown here, 
however, warrants caution in interpreting such results 
using heparin. They might as well imply that Ins 
1,3,4,5-P4 is involved. 
Finally, the Ins-P4 receptor prep~ation of porcine 
cerebellum solubilized and partially purified provides 
the possibility for isolating the receptor and thus deter- 
mining the molecular properties of the binding protein. 
Availability of the Ins-P4 receptor should allow testing 
the various hypotheses concerning the putative 
physiological role of Ins 1,3,4,5-P4 in cellular signal 
transduction. 
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